Wednesday, May 6, 2015 Last update: 12:33 AM - Covering Large & Obscure Tech Companies Since 1996

RegeneRx Biopharmaceuticals, Inc.

News articles for RegeneRx Biopharmaceuticals, Inc.:

Monday, May 4, 2015

Thursday, April 23, 2015

Thursday, April 16, 2015

Wednesday, April 1, 2015

Thursday, March 26, 2015

Wednesday, March 25, 2015

Monday, March 9, 2015

Tuesday, March 3, 2015

Wednesday, February 25, 2015

  • RegeneRx Receives Israeli Patent for Treating and Repairing Heart Damage
    ROCKVILLE, Md., Feb. 25, 2015 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx") today announced that it has received an Israeli patent with claims for preventing, inhibiting or reducing heart tissue deterioration, injury or damage, and for restoring heart tissue. The patent includes ... read more

Thursday, February 19, 2015

  • RegeneRx Updates Website
    ROCKVILLE, Md., Feb. 19, 2015 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx") updated its website to reflect recent commercial transactions and information related to development of its clinical products. The site can be accessed at About RegeneRx Biopharmaceuticals, Inc.RegeneRx is focused ... read more

Tuesday, February 17, 2015

  • RegeneRx Releases Letter to Shareholders
    ROCKVILLE, Md., Feb. 17, 2015 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx") today released the following letter to shareholders: Dear Shareholder: Having just completed a very important licensing and joint venture agreement to more rapidly move our ophthalmic drug candidate forward in the U.S., we ... read more

Wednesday, January 28, 2015

Monday, December 29, 2014

Tuesday, November 25, 2014